Breast Biopsy Market worth $728.8 Million by 2020

1. MarketsandMarkets Presents Breast Biopsy Market - Global Forecasts to 2020 https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

2. • The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020. • Major factors fueling market growth are the rising incidences of breast cancer among women and increase in breast cancer screening programs in different countries. In addition to this, the increase in reimbursement rates in U.S. for image-guided biopsy and the growing demand for less-invasive breast biopsy are propelling the growth of the market. • On the basis of type, the market is classified into needle and open surgical breast biopsy. The needle breast biopsy segment is expected to account for the largest share of the market, because of the increased preferences for needle biopsies over open surgical breast biopsies and the demand for scarless and painless surgical procedures. https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

3. https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-https://www.marketsandmarkets.com/Market-Reports/biopsy-devices- breast-biopsy-market-189011805.html Early buyers will receive 10% customization on reports. Geographically, the market is dominated by North America, followed by Europe. The market in Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Its high growth can be attributed to the rise in the purchasing power of the middle class and increasing awareness about breast cancer screening. https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

4. • The market is segmented on the basis of product, type, guidance, and region. The breast biopsy guidance market is categorized into mammography, ultrasound, MRI, and others (PET and thermography). In this market, the ultrasound segment is expected to be the fastest-growing segment owing to the increasing demand for minimally invasive and non-radiation breast biopsy among patients and surgeons. • On the basis of product, the market is classified into biopsy needles, guidance systems, biopsy tables, localization wires, and others (markers, punches, sutures). The growth of the segment can be attributed to the increasing demand for needle biopsies such as core-needle and vacuum-assisted biopsy globally. https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

5. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.linkedin.com/company/marketsandmarkets http://twitter.com/marketsmarkets https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

6. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, electronics, and telecommunications and IT. banking and financial services, pharmaceuticals, semiconductor and We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html